scPharmaceuticals Inc.
USD5.67
+0.00 (+0.00%)
CEO
John H. Tucker
IPO Date
2017-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.67
Prev. Close
$5.67
Day Low
$5.67
Day High
$5.67
52W Low
$1.94
52W High
$6.28
Market Cap
$0.30B
Volume
10.90M
| -4.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -50.9% | -29.7% | 0.52 | 16.63 | -5.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -49.6% | -35.5% | 0.31 | 5.27 | -4.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -39.2% | -29.5% | 0.25 | 11.57 | -4.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -67.0% | -44.5% | 0.39 | 14.44 | -3.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -37.4% | -31.4% | 0.14 | 13.77 | -2.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -22.5% | -19.5% | 0.11 | 23.01 | -1.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 65.8% | -61.3% | 0.00 | 10.64 | -6.5 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | 57.7% | -569.8% | 0.00 | 0.91 | -15.0 |
| -1.8 |
| 31 Dec 2024 | Q4 | 67.4% | -155.1% | -141.5% | -17.5% | 3.96 | 7.12 | -2.1 |
| 30 Sept 2024 | Q3 | 67.0% | -350.1% | -114.3% | -28.1% | 1.71 | 8.08 | -1.5 |
| 30 Jun 2024 | Q2 | 71.4% | -212.2% | -184.8% | -26.1% | 4.47 | 4.84 | -2.5 |
| 31 Mar 2024 | Q1 | 69.9% | -231.2% | -57.4% | -18.0% | 1.66 | 6.21 | -3.3 |
| 31 Dec 2023 | Q4 | 70.9% | -226.6% | -37.1% | -14.6% | 1.08 | 7.08 | -4.4 |
| 30 Sept 2023 | Q3 | 71.6% | -411.9% | -31.8% | -14.7% | 0.81 | 9.53 | -4.4 |
| 30 Jun 2023 | Q2 | 78.4% | -864.1% | 5.6% | -12.4% | -0.15 | 17.12 | -7.0 |
| 31 Mar 2023 | Q1 | 70.7% | -621.8% | 5.4% | -10.1% | -0.16 | 16.38 | -6.7 |